Does low selenium impair conversion of T4 to T3 and lower circulating T3 despite normal TSH and T4?

The claim that selenium is required for the deiodinase enzymes that convert T4 to T3, and that low selenium status can result in lower circulating T3 despite normal TSH and T4 levels, is strongly supported by mechanistic research and clinical observations.

Mechanistic evidence

Selenium is a structural and functional requirement for the three iodothyronine deiodinase enzymes (DIO1, DIO2, and DIO3). These enzymes are specialized "selenoproteins" that contain a selenocysteine (Sec) residue at their catalytic active site.

• Catalytic Activity: The conversion of thyroxine (T4) to the active hormone triiodothyronine (T3) occurs through a nucleophilic substitution reaction where the selenolate group on the enzyme attacks the iodine bond on T4.
• Enzyme Synthesis: Without adequate selenium, the body cannot effectively synthesize functional deiodinase proteins. Selenium status modulates the expression of the specialized machinery (such as SECIS-binding protein 2) required to insert selenium into the enzyme during protein production.
• Regeneration: The catalytic cycle produces a selenenyl-iodide intermediate that must be reduced by cellular thiol systems (like glutathione or thioredoxin) to return the enzyme to its active state.

Clinical and effectiveness evidence

In states of selenium deficiency, the capacity for peripheral conversion of T4 to T3 is compromised, leading to a distinct biochemical profile.

• Hormone Ratios: Low selenium status is consistently associated with a higher T4:T3 ratio. Studies in animal models have shown that severe selenium restriction can reduce hepatic T3 production by over 90%.
• TSH and T4 Stability: Because the conversion of T4 to T3 occurs largely in peripheral tissues (liver, kidneys, muscle), a selenium-related reduction in T3 can occur while TSH and T4 remain within conventional reference ranges. This is particularly noted in elderly populations, where long-term selenium supplementation has been shown to increase free T3 levels and stabilize TSH.
• Study Data: In clinical cohorts, lower dietary selenium intake correlates with lower free T3 levels (p < 0.01) and higher free T4 levels. However, meta-analyses suggest that in populations already sufficient in selenium, additional supplementation does not significantly raise T3, indicating the effect is most pronounced in those with baseline deficiency.

Practical considerations for older adults

For a 73-year-old female, selenium status may be particularly relevant as deiodinase efficiency can decline with age.

• Elderly Populations: Research indicates that selenium status often declines with age, and supplementation in this demographic has demonstrated the ability to improve the T3:T4 ratio and prevent the progressive rise of TSH.
• Subclinical Indicators: An elevated T4:T3 ratio in the presence of "normal" TSH may be a subtle clinical indicator of selenium-dependent conversion impairment.

Bottom line

Selenium is an essential cofactor for the enzymes that activate thyroid hormone. Deficiency impairs the conversion of T4 to T3, which can result in low circulating T3 levels even when standard thyroid markers (TSH and T4) appear normal, a phenomenon especially relevant in aging populations.